COMPOSITION FOR INHIBITING ACTIVITY OF GLYCOGEN SYNTHASE KINASE 3beta; CONTAINING EPIGALLOCATECHIN GALLATE

摘要

The invention epi- catechin gallate by glycogen synthase kinase 3 go as inhibitors (Epigallocatechin gallate, EGCG ) relates to a composition containing , more particularly, glycogen synthase kinase 3 expression or activity of glycogen synthesis by suppressing the increase of type 2 diabetes in the catechin gallate to epi- go that will be useful in the treatment relates to a composition containing as an active ingredient .